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The bacterial ribonuclease P or RNase P holoenzyme is usually composed of a catalytic
RNA subunit, M1, and a cofactor protein, C5. This enzyme was first identified for its
role in maturation of tRNAs by endonucleolytic cleavage of the pre-tRNA. The RNase P
endonucleolytic activity is characterized by having structural but not sequence substrate
requirements. This property led to development of EGS technology, which consists
of utilizing a short antisense oligonucleotide that when forming a duplex with a target
RNA induces its cleavage by RNase P. This technology is being explored for designing
therapies that interfere with expression of genes, in the case of bacterial infections
EGS technology could be applied to target essential, virulence, or antibiotic resistant
genes. Acinetobacter baumannii is a problematic pathogen that is commonly resistant to
multiple antibiotics, and EGS technology could be utilized to design alternative therapies.
To better understand the A. baumannii RNase P we first identified and characterized
the catalytic subunit. We identified a gene coding for an RNA species, M1Ab, with the
expected features of the RNase P M1 subunit. A recombinant clone coding for M1Ab
complemented the M1 thermosensitive mutant Escherichia coli BL21(DE3) T7A49,
which upon transformation was able to grow at the non-permissive temperature. M1Ab
showed in vitro catalytic activity in combination with the C5 protein cofactor from E. coli
as well as with that from A. baumannii, which was identified, cloned and partially purified.
M1Ab was also able to cleave a target mRNA in the presence of an EGS with efficiency
comparable to that of the E. coli M1, suggesting that EGS technology could be a
viable option for designing therapeutic alternatives to treat multiresistant A. baumannii
infections.
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INTRODUCTION
Ribonuclease P, or RNase P, is a ubiquitous ribozyme that was first identified for its participation
in the maturation of the precursor tRNA (pre-tRNA) by endonucleolytic cleavage at the 5′-end
of the molecule (Robertson et al., 1972). Later, it was shown that RNase P participates in other
biological processes like the synthesis of other RNA species such as transfer messenger RNA,
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precursors to 4.5S RNA, some multicistronic mRNAs, small non-
coding RNA genes, phage-related RNAs, and others (Bothwell
et al., 1976; Alifano et al., 1994; Komine et al., 1994; Hartmann
et al., 1995; Reiner et al., 2006; Yang and Altman, 2007; Jarrous
and Gopalan, 2010; Altman, 2011; Klemm et al., 2016). The
RNase P holoenzyme is a ribonucleoprotein composed by the
RNA molecule responsible for its catalytic activity, known as
M1 in Escherichia coli (M1Ec), and one or more proteins that
act as cofactors (Guerrier-Takada et al., 1983; Marvin and
Engelke, 2009; Jarrous, 2017). In particular, bacterial RNase P
holoenzymes usually contain only one small cofactor protein,
called C5 in E. coli (C5Ec) (Reiter et al., 2010; Mondragon,
2013). Numerous studies on the RNase P enzymes from different
organisms belonging to all three life domains showed many
common structural features among the RNA components and
a common core with similar secondary structure (Chen and
Pace, 1997; Mondragon, 2013). Three types of RNA components
of RNase P were identified in bacteria, the most common are
known as types A (for ancestral) and B (for Bacillus); type C
includes RNA molecules from green non-sulfur bacteria (Haas
and Brown, 1998). For a comparative structural diagram among
all three types see the review by Mondragon (Mondragon,
2013). The RNA components of bacterial RNase P include two
domains, one of them called C (catalytic) that recognizes the
acceptor stem and the 3′-CCA sequence of the substrate RNA
and mediates the endonucleolytic cleavage. The other domain is
called S (specificity) and is responsible for substrate recognition
(Mondragon, 2013). Crystallographic studies on bacterial RNase
P are limited, only the three-dimensional structures of the intact
Thermotogamaritima RNA component and a fragment including
the C domain of that of Bacillus stearothermophilus are available
(Kazantsev et al., 2005; Torres-Larios et al., 2005). However,
although not at the structural level, the E. coli RNase P, which
consists of the 377-nucleotides catalytic RNA subunit M1Ec and
the 119-amino acids cofactor protein C5Ab, is one of the best
characterized (Guerrier-Takada et al., 1983). RNase P requires a
particular structure in the substrate RNA that includes a double-
stranded region (acceptor stem) followed by a single-stranded
stretch that includes the RCCA sequence at the 3′ end, which
facilitates interaction with the enzyme (Figure 1). One of the
two complementary segments of the acceptor stem is called
“external guide sequence” (EGS) and is instrumental in guiding
RNase P to cleave the opposite strand during the maturation
process (Figure 1). With the exception of the acceptor stem,
most other regions of the substrate RNA can be deleted without
completely abolishing RNase P activity and, although essential
for cleavage, the EGS is not required to be tethered to the
rest of the molecule (Forster and Altman, 1990; Gopalan et al.,
2002; Figure 1). Furthermore, cleavage is not dependent on
the sequence of the substrate (Figure 1). This finding was the
foundation of the EGS technology, a gene silencing strategy in
which a short oligomer (EGS) interacts with a target RNA, usually
mRNA, and elicits its cleavage, interfering with expression of the
gene (Lundblad and Altman, 2010). EGS Technology approaches
have been explored as alternatives to design therapeutic tools
or antibiotic adjuvants for treatment of multidrug resistant
bacterial infections (Guerrier-Takada et al., 1997; Soler Bistue
FIGURE 1 | Diagram showing the structure of the pre-tRNA and the location
of the endonucleolytic cleavage by RNase P (left). The diagram to the right
shows a complex between two RNA molecules with a complementary region
that form the appropriate structure to be recognized as substrate by RNase P.
The different colors illustrate the fact that while there are structural
requirements, RNase P does not show specificity of sequence. The antisense
regions in the acceptor stem and the EGS are shown as dashed lines. The
RCCA sequence facilitates the interaction between the substrate and
RNase P.
et al., 2007, 2009; Ko et al., 2008; Shen et al., 2009; Sawyer et al.,
2013).
Acinetobacter baumannii is a nosocomial pathogen that
belongs to the ESKAPE group of pathogens and causes a wide
range of severe infections, mainly among immunocompromised
patients (Wong et al., 2017; Harding et al., 2018). Treatment
of these infections is complicated by the multidrug-resistant
nature of most strains, a characteristic that led to inclusion of
A. baumannii in the priority list of antibiotic-resistant bacteria
by the World Health Organization (Doi et al., 2017; Tacconelli
et al., 2018; Tacconelli and Magrini, 2018). As a consequence,
there is a high need for new treatments of A. baumannii
and development of EGSs that inhibit expression of essential
functions or antibiotic-resistance genes could be an alternative
(Sala et al., 2012). A better understanding of the A. baumannii
RNase P will be beneficial for EGS Technology development of
therapies to treat multidrug resistant infections caused by this
bacterium.
MATERIALS AND METHODS
Bacterial Strains and Plasmids
Acinetobacter baumannii ATCC 17978 (Smith et al., 2007)
was used as source of genomic DNA and the primers were
designed using the complete genome sequence (Accession
No. CP000521.1). E. coli DH5α (Taylor et al., 1993) and
BL21(DE3) (Studier et al., 1990) were used as hosts for cloning
experiments. E. coli BL21(DE3) T7A49 is a thermosensitive
M1 mutant (Guerrier-Takada et al., 1995). Plasmid pM1Ab
was generated by inserting a DNA fragment including the
A. baumannii rnpB gene (rnpBAb) under the control of the T7
promoter into the cloning vector pCR2.1 (Life Technologies).
This fragment was an amplicon generated using A. baumannii
ATCC 17978 chromosomal DNA as template and the primers 5′-
GCAAGCTTTAATACGACTCACTATAGGGGAAGTGAGCCG
GATGGTC-3′ (the T7 promoter is underlined) and 5′-
GCAGGATCCAGGTGAAGTGAGCCTATAAGCC-3′. The
sequence of EGSA2 was 5′-CGAUAUGAGAUCGACCA-3′.
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Plasmid pC5Ab was generated by ligating an amplicon including
the A. baumannii rnpA gene (rnpAab) to NdeI and XhoI-digested
pET22(+) (Novagen). The amplicon was obtained using the
primers 5′-GCCCATATGGTGCATCAACCCCATTTTTT-3′
and 5′-GAACTCGAGATTCTGCGAGGTTGGGACA-3′. The
recombinant plasmid pC5Ab codes for the A. baumannii C5
(C5Ab) protein fused to a His-tag at the C-terminus under the
control of the T7 promoter.
General Procedures
Plasmid DNA preparations were carried out using the Wizard R©
Plus SV Minipreps DNA Purification System (Promega).
Endonuclease restriction and ligase treatments were performed
according to the recommendations of the supplier (New England
Biolabs). Polymerase chain reactions were carried out using
Taq DNA Polymerase (Invitrogen) and the primers indicated
(purchased from IDT Technologies), following the supplier’s
recommendations. In vitro synthesis of RNA molecules was
done using a MEGAshortscript high-yield transcription T7 kit
according to the protocols provided by the supplier (Ambion).
Denaturing polyacrylamide gel electrophoresis was performed as
described previously (Sarno et al., 2003) on 6% polyacrylamide
19:1 (acrylamide–bis-acrylamide), gels containing 7 M urea
using a Tris-Borate-EDTA buffer (TBE) or glycerol-tolerant
gel (GTG) buffer. Electrophoresis of an aliquot of the M1Ab
purified transcript is shown in Supplementary Figure S1A. DNA
and RNA sequence analyses were carried out using Basic local
alignment search tool (BLAST) (Altschul et al., 1990), MUSCLE
(Edgar, 2004), and Bcheck (Yusuf et al., 2010). E. coli M1 (M1Ec)
and C5 (C5Ec) were purified as described before (Guerrier-
Takada et al., 1983).
Overexpression of C5Ab was carried out culturing E. coli BL21
(DE3; pC5Ab) in LB broth containing 100 µg of ampicillin/ml
at 37◦C until the optical density at 600 nm (OD600) was 0.8.
At this point isopropyl β-D-galactopyranoside (IPTG) was added
to a concentration of 0.5 mM, the culture was incubated for
90 m at 28◦C, and the cells were harvested by centrifugation
and suspended in phosphate buffer saline (PBS) buffer (20 mM
sodium phosphate and 300 mM sodium chloride) pH 7.4. Cells
were lysed by French press at 1000 psi (three passages) followed
by centrifugation at 4000 g at 4◦C for 15 min to remove cell
debris. The supernatant was centrifuged at 13500 g at 4◦C
for 20 min and the supernatant was subjected to one last
centrifugation at 100000 g for 1 h at 4◦C. The supernatant
containing the soluble fraction was used for purification of
C5Ab. The protein was purified by immobilized metal affinity
chromatography (IMAC) using a nickel-charged nitrilotriacetic
acid (NTA) resin column (Thermo Scientific HisPur Ni-NTA
Spin Columns) following the recommendations of the supplier.
Once eluted using PBS containing 250 mM imidazole and
6 M Guanidine HCl, pH 7.4, the samples were dialyzed
against PBS at 4◦C. Proteins were analyzed using sodium
dodecyl sulfate 15% polyacrylamide gel electrophoresis (SDS-
PAGE)(Laemmli, 1970) followed by staining with Coomassie
Brilliant Blue. Nucleotide and amino acid sequence analyses and
comparisons were performed using the Clustal Omega and the
BLAST programs (Altschul et al., 1990; Sievers et al., 2011).
The prediction of physical and chemical parameters, search
of specific domains, and modeling were carried out using the
ProtParam, Pfam, and SWISS-MODEL, respectively (Gasteiger
et al., 2005; Finn et al., 2014; Bienert et al., 2017). An SDS-PAGE
analysis of the purified C5Ab protein is shown in Supplementary
Figure S1B.
In vitro RNase P Assays
Unimolecular substrate: the reaction contained pre-tRNATyr
(80 pmol), M1Ec or M1Ab (40 pmol), C5EC or C5Ab (50 pmol;
when indicated) in C5 buffer (20 mM HEPES-KOH pH = 8,
400 mM ammonium acetate, 10 mM magnesium acetate,
5% glycerol) in a total volume of 10 µl. Incubation was
performed at 37◦C for 90 m. Bimolecular substrate: aac(6)′-
Ib mRNA (40 pmol) was incubated with EGS (50 pmol) at
room temperature for 15 min. Simultaneously, M1Ab (40 pmol)
was incubated with C5Ec (50 pmol) in C5 buffer at 37◦C
for 15 min. Both fractions were combined and incubated for
90 min at 37◦C. The reaction was stopped by heating and
subjected to phenol/chloroform extraction followed by ethanol
precipitation as described before (Jani et al., 2018). The products
were resuspended in 1 volume of gel loading buffer and analyzed
by 6% denaturing TBE-PAGE or GTG-PAGE (Soler Bistue et al.,
2009). RNA bands were visualized by staining with ethidium
bromide and UV transillumination.
M1 Heterologous Complementation
Assays
Escherichia coli BL21(DE3) T7A49 and E. coli BL21(DE3) T7A49
(pM1Ab) were incubated in LB broth for 24 h at 28 or 42◦C,
with or without 0.1 mM IPTG. Bacterial growth was determined
by measuring OD600. Assays were carried out in duplicate and
repeated three times. Statistical significance was analyzed by one-
way ANOVA with Dunnett’s multiple comparison test. P < 0.05
was considered statistically significant.
RESULTS AND DISCUSSION
A BLAST search using as query the E. coli rnpB nucleotide
sequence (Accession No. NCBI Gene ID 947634) and the
complete genome of A. baumannii ATCC 17978 as subject
(Accession No. GenBank: CP000521.1) identified a region
(coordinates 987928–988235) with 80% identity to the E. coli
rnpB that was called rnpBAb. A comparative analysis of the
nucleotide sequence of this region to the rnpB genes from E. coli
and Klebsiella pneumoniae (Accession No. GenBank: M32719.1)
(Lawrence et al., 1987) permitted us to determine the rnpBAb
promoter region as well as the first and last nucleotide of the
RNA molecule encoded, called M1Ab (Figure 2A). Inspection
of the M1Ab sequence shows that it belongs to the type A
group of RNase P catalytic subunits and includes the conserved
regions (Chen and Pace, 1997; Mondragon, 2013). Further
analysis using Bcheck (Yusuf et al., 2010) identified the M1Ab
sequence as an RNase P RNA. The high level of identity between
the sequence of rnpBAb and those from the rnpB genes from
E. coli and K. pneumoniae extends from the −10 nucleotide
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FIGURE 2 | Alignment of the nucleotide sequences of the coding and promoter regions of RNA subunit (M1) of the ribonuclease P from Escherichia coli, Klebsiella
pneumoniae, and Acinetobacter baumannii. (A) Multiple alignment of the coding sequences of M1 performed using MUSCLE. The yellow rectangles show
nucleotides belonging to the universally Conserved Regions present in RNA subunits of RNase P (Chen and Pace, 1997), each region is indicated in roman numbers.
(B) Alignment of the promoter regions.
in the promoter region (Lawrence et al., 1987) to the 3′ end
of the RNA molecule. Conversely, the −35 and spacer regions
show divergence (Figure 2B). This could be a consequence of
adaptation to different properties between the RNA polymerases
from A. baumannii and the two Enterobacteriaceae. Future
comparative studies of expression and activity levels in all three
bacteria may lead to a better understanding of the significance of
these differences.
The rnpBAb gene was cloned under the control of the
T7 promoter and the 355-nt M1Ab RNA was synthesized
in vitro as described in section “Materials and Methods”
(Supplementary Figure S1A). The synthesized product was
tested to determine its RNase P activity using as substrate pre-
tRNATyr. Figure 3 shows that both M1Ab and the M1Ec cleaved
the substrate with similar efficiency in the presence of the cofactor
protein C5Ec and were inactive in the absence of the protein in
the conditions used in the assay. Previous work carried out with
M1 showed that at certain magnesium concentrations in vitro,
cleavage occurs in the absence of C5 (Guerrier-Takada et al.,
1983). The results of the experiment shown in Figure 3 not
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FIGURE 3 | In vitro activity of the RNA subunit of the ribonuclease P from Acinetobacter baumannii (M1Ab). The unimolecular substrate pre-RNAtTyr, was used for
the reaction performed as described in section “Materials and Methods”. The reaction was analyzed on denaturing PAGE. The location and size of the substrate and
the cleavage product are indicated to the left and right, respectively. Ab, A. baumannii and Ec, E. coli. C5
FIGURE 4 | Heterologous complementation of strain E. coli BL21(DE3) T7A49. The M1EC thermosensitive mutant was transformed with pM1Ab, a plasmid encoding
M1Ab under the control of a T7 promoter. E. coli BL21(DE3) T7A49 (T7A49) and E. coli BL21(DE3) T7A49 (pM1Ab) (T7A49M1) were cultured in the presence (IPTG)
or absence of 0.1 mM IPTG Growth was assessed measuring OD600. Statistical analysis was carried out using one-way ANOVA and Dunnett’s multiple comparison
test. ∗ indicates statistical significance (P < 0.05).
only confirmed that the M1Ab RNA is the A. baumannii RNase
P catalytic subunit, but also that it is active in the presence of
a heterologous cofactor as it is the C5Ec protein. To confirm
the activity of M1Ab in vivo, we carried out an experiment
using the M1 thermosensitive mutant E. coli BL21(DE3) T7A49,
which does not grow at the non-permissive temperature (42◦C).
This strain was transformed with the plasmid pM1Ab and the
transformant strain was cultured at 28 and 42◦C in the presence
or absence of IPTG. Figure 4 shows that the E. coli BL21(DE3)
T7A49(pM1Ab) acquired the ability to grow at 42◦C when
expression of M1Ab was induced by addition of IPTG, indicating
that RNase P function was restored. This result showed that, as
it was the case for the in vitro reaction, M1Ab could interact with
C5Ec and produce a functional RNase P in vivo.
Studies on the RNase P showed that most of the pre-
tRNA substrate molecule could be removed without affecting
its activity (Gopalan et al., 2002; Lundblad and Altman, 2010).
Furthermore, bimolecular complexes were also substrates as
long as they form the appropriate structure regardless of
the nucleotide sequence (Gopalan et al., 2002; Lundblad and
Altman, 2010). These findings originated what is known as
EGS technology, which takes advantage of the host RNase
P activity to induce degradation of a target mRNA in the
presence of an antisense oligonucleotide known as EGS (Gopalan
et al., 2002; Lundblad and Altman, 2010; Davies-Sala et al.,
2015). This technology could be an option for designing
antimicrobials that target essential A. baumannii functions or
adjuvants that inhibit expression of resistance genes and would
be used in combination with the appropriate antibiotic to
restore its therapeutic power. We assessed the ability of M1Ab
to elicit cleavage of a target mRNA in the presence of an
EGS (bimolecular RNA substrate) in comparison to that of
M1EC. For this we used a bimolecular substrate consisting
of the aac(6’)-Ib mRNA, which codes for an acetyltransferase
that catalyzes inactivation of several aminoglycosides of clinical
relevance (Ramirez and Tolmasky, 2010; Ramirez et al., 2013),
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FIGURE 5 | Acinetobacter baumannii RNase P RNA subunit and its application for EGS technology. In vitro activity of the M1Ab, RNA subunit of ribonuclease P of
A. baumannii in presence of a bimolecular substrate. The substrate is composed of mRNA aac(6)′-Ib and EGSA2. The reaction was analyzed on denaturing PAGE.
On the left is shown the location of the substrate, M1Ab and cleavage products. Molecular size standards are shown to the right. Ab, A. baumannii and Ec, E. coli. C5
FIGURE 6 | C5Ab protein. (A) C5Ec and C5Ab amino acid sequence comparison. (B) In vitro activity of the reconstituted RNase P holoenzymes. The substrate
pre-RNAtTyr was incubated with the subunits indicated on top in the conditions described in section “Materials and Methods”. The reaction was analyzed on
denaturing PAGE, the fourth and fifth wells were run in the same gel but were not contiguous to the first three. The location and size of the substrate and the
cleavage product are indicated to the left and right, respectively. Ab, A. baumannii and Ec, E. coli.
and an EGS, EGSA2, that elicits cleavage of the mRNA by
the E. coli RNase P holoenzyme (Soler Bistue et al., 2009).
Figure 5 shows that the reactions carried out with both
M1EC and M1Ab produced the same level of degradation of
the aac(6’)-Ib mRNA strongly suggesting that EGS technology
could be an alternative for novel treatments of A. baumannii
infections.
Further analysis of the A. baumannii ATCC17978 genome
sequence permitted us to identify an open reading frame
potentially coding for C5Ab, the A. baumannii RNase P cofactor
protein. Amino acid sequence comparison between the C5Ec and
C5Ab proteins showed low similarity throughout most of the
sequence. However, a shared conserved 30-amino acid central
core characteristic of C5 proteins was identified (Figure 6A,
highlighted in yellow). The C5Ab predicted isoelectric point
was 10.8, characteristic of nucleic acids-binding proteins. Pfam
analysis predicted this protein to possess a domain (amino acids
2–86) corresponding to cofactors of RNase P family proteins.
The C5Ab protein was used to reconstitute the A. baumannii
holoenzyme. Figure 6B shows that M1Ab or M1Ec were activated
in the presence of C5Ab when tested using pre-tRNAtyr as
substrate.
In conclusion, the results described in this study indicate
that we identified the A. baumannii ATCC 17978 RNase P
gene coding for the catalytic subunit, M1Ab, and showed that
its activity is comparable to that of the E. coli M1 subunit.
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M1Ab was functional in the presence of C5Ec as well as
C5Ab, the latter of which was partially purified after the gene
was identified and cloned. Furthermore, the M1Ab ability to
cleave otherwise non-substrate target mRNAs in the presence
of an adequate EGS indicates that EGS technology could be
a viable option for designing therapeutic alternatives to treat
multiresistant A. baumannii infections. However, numerous
challenges remain to be addressed before this technique can
be reduced to practice. Non-hydrolyzable, but active analogs
must be designed to ensure stability. Also, the compound
must efficiently penetrate the cells once it reached the site
of infection. Promising but still preliminary results have
been obtained testing conjugates between nuclease resistant
hybrid locked nucleic acids (LNA)/DNA oligomers and the cell
penetrating peptide (RXR)4XB (where R stands for arginine,
X for 6-aminohexanoic acid, and B for beta-alanine) (Jackson
et al., 2016; Jani et al., 2018). Although previous reports
indicate that antisense compounds containing LNA and DNA
nucleotides show low toxicity (Wahlestedt et al., 2000), once
a specific compound is identified as a candidate for treatment
of A. baumannii infections, its cytotoxicity will have to be
determined.
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